Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy

NCT04015141 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT04015141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04015141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 31, 2019
Completion date
December 23, 2027
Enrollment
100 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

partial-onset seizures, pediatric epileptic syndrome